In STEMI patients with cancer, early mortality is primarily driven by cardiovascular disease, while late mortality (within 1 year) is predominantly due to cancer.
Answers are grounded in this paper and cite their sources.
Highlights competing mortality risks in STEMI patients with cancer; leaves open optimal management strategies pending prospective studies.
STEMI patients with cancer have a higher risk of short- and long-term mortality, particularly lung cancer. Colon cancer is the main cancer associated with major bleeding. Cardiovascular disease was the main cause of death in the first month, whereas cancer was the main cause of death within 1 year.
No takes yet. Share an insight, caveat, or question.
Dafaalla et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: